Skip to content
Medical Health Aged Care

UNSW expert available to comment on PBAC rejection of Mounjaro

UNSW Sydney < 1 mins read

The Pharmaceutical Benefits Advisory Committee (PBAC) has rejected the application to subsidise Mounjaro, the diabetes drug that can also be used for weight loss (similar to Ozempic). 

Dr Namson Lau is available to provide expert commentary, and can be contacted at namson.lau@sydney.edu.au

Dr. Namson Lau is a Conjoint Senior Lecturer, UNSW Sydney, and consultant endocrinologist at Liverpool and Royal Prince Alfred Hospitals.  His PhD was in neuro-endocrine regulation of appetite and weight and he has extensive clinical and research expertise in type 2 diabetes, complex obesity and cardio-metabolic management.  

More from this category

  • Medical Health Aged Care
  • 23/12/2024
  • 22:11
BeiGene, Ltd.

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN MATEO, Calif.–BUSINESS WIRE– BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne…

  • Contains:
  • Medical Health Aged Care
  • 23/12/2024
  • 12:57
Royal Australian College of GPs

RACGP: Look after your mental health this holiday season

The Royal Australian College of GPs (RACGP) has urged Australians to look after themselves and their loved ones this holiday season. College President, Dr Michael Wright, said that reaching out and helping others can make all the difference. “The holiday season can be a challenging time for many Australians,” he said. “Many of us can have family and relationship pressures, financial pressures may become more obvious, and isolation and loneliness can be at their worst this time of year too. So, during this festive season please try to look after yourself and the people in your life. It can be…

  • Medical Health Aged Care
  • 23/12/2024
  • 07:00
Monash University

What can your poo reveal about your heart health?

Human and microbial proteins found in poo could help doctors detect a long-term risk of deadly cardiovascular conditions in otherwise healthy patients, avoiding the need for costly and invasive diagnostic procedures. A new study from Monash University published today has linked the presence of certain faecal proteins to conditions like heart failure, and found they can be used as an early indicator of risk and outcomes. This is a breakthrough in the early prevention and diagnosis of conditions that could otherwise go hidden until they become fatal. Dr Francine Marques, a Monash Professor in the School of Biological Sciences and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.